Intracanalicular Dexamethasone Used in Conjunction With LipiFlow for the Treatment of Meibomian Gland Dysfunction in Patients With Evaporative Dry Eye Disease and Evidence of Clinically Significant Inflammation
Latest Information Update: 20 Apr 2022
At a glance
- Drugs Dexamethasone (Primary)
- Indications Dry eyes; Meibomian gland dysfunction
- Focus Therapeutic Use
Most Recent Events
- 11 Apr 2022 Status changed from recruiting to completed.
- 03 Sep 2020 Status changed from not yet recruiting to recruiting.
- 04 Jun 2020 New trial record